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 Reports on the isolation and identification of unusual 
 Mycobacteria species in humans, animals and plants 
have increased considerably recently due, largely, to the 
implementation of Molecular Biology methods which 
have higher discriminative powers than the classical phe-
notype-based techniques  [1] . Since the year 2000, several 
authors have identified a variety of  Mycobacteria in clini-
cal specimens, including  M. elephantis  [2, 3] ,  M. branderi 
 [4] ,  M. monacense  [5, 6] , and  M. poriferae  [7] . 
 M. madagascariense was first described by Kazda et al. 
 [8] . It grows rapidly at temperatures ranging between 22 ° C 
and 31 ° C and is scotochromogenic  [1] . Phylogeny studies 
based on DNA sequence classify M. madagascariense 
within the group of thermo-tolerant rapid growers, 
phylo-genetically close to M. confluentis  [9] . Experimen-
tal studies in animals indicate that this microorganism is 
not a pathogen  [1] . To date, M. madagascariense has not 
been identified in any human sample. The present letter 
reports, to the best of our knowledge for the first time in 
the literature, the identification of M. madagascariense in 
the sputum of a patient with tracheobronchitis. 
 In August 2009, a 22-year-old Russian male was admit-
ted to the Pneumology Department of the  Hospital Univer-
sitari Sant Joan de Reus (Catalonia, Spain). He complained 
of a cough with purulent sputum dating from a year previ-
ously, with bloody sputum on occasions. He had no evi-
dence of fever or toxic syndrome. Standard biochemical 
and hematological tests were normal. Serology for hepa-
titis B and C and human immunonodeficiency virus (HIV) 
infection were negative. Thorax X-ray showed calcified 
adenopathies in the right mediastinum and hilium, indi-
cating previous tuberculosis. Three serial sputum samples 
were collected and Zhiel-Neelsen staining was negative. 
A standard culture in agar plates was negative for bacte-
rial respiratory pathogens. Cultures in Lowenstein-Jensen 
(LJ) medium with pyruvate (but not LJ medium alone) 
showed, 7 days later, abundant mucous, 2 mm sized, 
acid-fast, orange colonies, that were composed of Gram-
positive rods. Acid fast bacilli staining was performed in 
the sputum samples before and after decontamination, 
and prior to inoculation into the LJ medium. These colo-
nies were identified as  M. madagascariense using molecu-
lar and phenotypic methods in a reference laboratory at 
the  Hospital Universitari de Bellvitge (Barcelona, Spain). 
Currently, this mycobacterial species cannot be identified 
by routine commercial tests since the organism is not rec-
ognized with the available diagnostic systems. Although 
growth and chromogenic characteristics as well as bio-
chemical tests (Table  1 ) were important for microbiology 
diagnosis, definitive identification relied on partial 16S 
rRNA gene sequencing (first 500 bp)  [10] . The patient was 
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treated for his tracheobronchitis with amoxicillin/clavula-
nate with favorable evolution and was referred back to the 
primary care physician for monitoring. 
 The source of this  M. madagascariense infection 
could not be ascertained from questioning the patient 
or from the data available in the medical history. This 
bacterium was first described after the isolation of three 
strains from several species of sphagnum moss found 
between Toalanaro and Saint-Luce in the coastal region 
of Madagascar  [8] . Sphagnum is widely distributed in 
the Northern Hemisphere, especially in tundra regions, 
Characteristics Result
Colony morphology Smooth
Pigmentation Scotochromogenic
Growth
   < 7 days Positive
   22 ° C Positive
   31 ° C Positive
   37 ° C Negative
Enzymatic activities
   Arylsulfatase (3 days) Positive
   Urease Positive
   Nitrate reductase Negative
   Tween hydrolysis (10 days) Positive
   Pyrazinamidase Positive
   NaCl (5 % ) tolerance Negative
   Iron uptake Positive
Carbohydrate utilization
   D-Glucose Positive
   L-Arabinose Positive
   D-Fructose Positive
   D-Mannitol Positive
 Table 1   Phenotypic characteristics of  M. madagascariense. 
since it is used as a soil conditioner and as a building 
insulating material. Hence, the possibility exists that 
the infection was acquired by the patient in his country 
of origin.  M. madagascariense is considered non- 
pathogenic  [1] and, as such, an association between the 
presence of this bacterium and the pathophysiology of 
the tracheobronchitis is questionable. It is possible that 
the patient was contaminated by a few bacterial cells 
acquired from his environment. It needs to be noted 
that all mycobacteria are very resistant to bactericidal 
activity of macrophages and that, especially in the pre-
sence of a concomitant infection, might be very difficult 
to clear. It is also possible that the patient was allergic 
to sphagnum and the allergic reaction was related to the 
tracheobronchitis. However, all these considerations do 
not rule out a possible role of  M. madagascariense in 
human pathology, especially in immunocompromized 
patients. 
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